Bank of Montreal
FLNA

Bank of Montreal’s Filana Therapeutics FLNA Stock Holding History

Bank of Montreal’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,300
Closed -$105K – 4188
2024
Q2 		$105K Buy
+5,300
New +$112K ﹤0.01% 3222

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of Montreal's FLNA Position: Q3 2024 in Review

Bank of Montreal sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 6,910 shares — an estimated $137K sold.

Bank of Montreal first reported a position in FLNA in Q1 2020 and held it in 8 quarters. The position peaked at $606K in Q3 2023. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Bank of Montreal reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 6,910 Filana Therapeutics shares in Q3 2024, an estimated $137K.
  • Bank of Montreal first reported a position in Filana Therapeutics in Q1 2020 and held it in 8 quarters.
  • Bank of Montreal's Filana Therapeutics position peaked at $606K in Q3 2023.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.